OBJECTIVE: To evaluate pain, fatigue, and psychological functioning of childhood-onset systemic lupus erythematosus (SLE) patients and examine how these factors impact health-related quality of life (HRQOL). METHODS: At a tertiary rheumatology clinic, 60 childhood-onset SLE patients completed the following: a visual analog scale (VAS) of pain intensity (0-10), the Pediatric Quality of Life (PedsQL) multidimensional fatigue scale, Pain Coping Questionnaire, Pain Catastrophizing Scale (PCS), Children's Depression Inventory I (CDI-I), the Screen for Child Anxiety Related Emotional Disorders (SCARED) questionnaire, and the PedsQL generic core (GC) scale and rheumatology module (RM). Sociodemographics and multiple disease activity indicators were recorded. RESULTS: Fatigue was present in 65% of the patients. Clinically relevant pain (pain-VAS >3), anxiety (SCARED ≥25), and depressive symptoms (CDI-I >12) were observed in 40%, 37%, and 30% of the patients, respectively; 22% had high catastrophizing (PCS ≥26). On average, the PedsQL-GC and -RM scores for childhood-onset SLE were lower than in healthy norms. Reduced PedsQL-GC and -RM scores were highly correlated with greater levels of fatigue, anxiety, and depressive symptoms (Pearson's r > 0.65), but had weak correlation with disease activity (Pearson's r < 0.25). Regression analysis demonstrated HRQOL was most impacted by fatigue, pain, and anxiety when evaluating all factors concurrently (P < 0.001). CONCLUSION: Childhood-onset SLE is associated with decreased HRQOL, and psychological aspects of health contribute substantially to low HRQOL, whereas measures of childhood-onset SLE activity seem less relevant. Fatigue, pain, mood, and anxiety symptoms are present in a large subgroup of patients and need medical attention to achieve optimal health outcomes.
OBJECTIVE: To evaluate pain, fatigue, and psychological functioning of childhood-onset systemic lupus erythematosus (SLE) patients and examine how these factors impact health-related quality of life (HRQOL). METHODS: At a tertiary rheumatology clinic, 60 childhood-onset SLEpatients completed the following: a visual analog scale (VAS) of pain intensity (0-10), the Pediatric Quality of Life (PedsQL) multidimensional fatigue scale, Pain Coping Questionnaire, Pain Catastrophizing Scale (PCS), Children's Depression Inventory I (CDI-I), the Screen for ChildAnxiety Related Emotional Disorders (SCARED) questionnaire, and the PedsQL generic core (GC) scale and rheumatology module (RM). Sociodemographics and multiple disease activity indicators were recorded. RESULTS:Fatigue was present in 65% of the patients. Clinically relevant pain (pain-VAS >3), anxiety (SCARED ≥25), and depressive symptoms (CDI-I >12) were observed in 40%, 37%, and 30% of the patients, respectively; 22% had high catastrophizing (PCS ≥26). On average, the PedsQL-GC and -RM scores for childhood-onset SLE were lower than in healthy norms. Reduced PedsQL-GC and -RM scores were highly correlated with greater levels of fatigue, anxiety, and depressive symptoms (Pearson's r > 0.65), but had weak correlation with disease activity (Pearson's r < 0.25). Regression analysis demonstrated HRQOL was most impacted by fatigue, pain, and anxiety when evaluating all factors concurrently (P < 0.001). CONCLUSION: Childhood-onset SLE is associated with decreased HRQOL, and psychological aspects of health contribute substantially to low HRQOL, whereas measures of childhood-onset SLE activity seem less relevant. Fatigue, pain, mood, and anxiety symptoms are present in a large subgroup of patients and need medical attention to achieve optimal health outcomes.
Authors: Susmita Kashikar-Zuck; Tracy V Ting; Lesley M Arnold; Judy Bean; Scott W Powers; T Brent Graham; Murray H Passo; Kenneth N Schikler; Philip J Hashkes; Steven Spalding; Anne M Lynch-Jordan; Gerard Banez; Margaret M Richards; Daniel J Lovell Journal: Arthritis Rheum Date: 2012-01
Authors: Susmita Kashikar-Zuck; Soumitri Sil; Anne M Lynch-Jordan; Tracy V Ting; James Peugh; Kenneth N Schikler; Philip J Hashkes; Lesley M Arnold; Murray Passo; Margaret M Richards-Mauze; Scott W Powers; Daniel J Lovell Journal: J Pain Date: 2013-03-26 Impact factor: 5.820
Authors: Kristen E Jastrowski Mano; Jenny R Evans; Susan T Tran; Kim Anderson Khan; Steven J Weisman; Keri R Hainsworth Journal: J Pediatr Psychol Date: 2012-06-07
Authors: Susmita Kashikar-Zuck; Stacy R Flowers; Robyn Lewis Claar; Jessica W Guite; Deirdre E Logan; Anne M Lynch-Jordan; Tonya M Palermo; Anna C Wilson Journal: Pain Date: 2011-03-31 Impact factor: 6.961
Authors: S Ahola Kohut; T S Williams; J Jayanthikumar; C Landolt-Marticorena; A Lefebvre; E Silverman; D M Levy Journal: Lupus Date: 2013-05-23 Impact factor: 2.911
Authors: Andrea Knight; Amy J Kogon; Matthew B Matheson; Bradley A Warady; Susan L Furth; Stephen R Hooper Journal: J Pediatr Date: 2017-07-19 Impact factor: 4.406
Authors: J A Román Ivorra; N Fernández-Llanio-Comella; A San-Martín-Álvarez; P Vela-Casasempere; I Saurí-Ferrer; S González-de-Julián; D Vivas-Consuelo Journal: Clin Rheumatol Date: 2019-02-28 Impact factor: 2.980
Authors: Jordan T Jones; Adam C Carle; Janet Wootton; Brianna Liberio; Jiha Lee; Laura E Schanberg; Jun Ying; Esi Morgan DeWitt; Hermine I Brunner Journal: Arthritis Care Res (Hoboken) Date: 2016-11-28 Impact factor: 4.794
Authors: Michelle Quilter; Linda Hiraki; Andrea M Knight; Julie Couture; Deborah Levy; Earl D Silverman; Ashley N Danguecan; Lawrence Ng; Daniela Dominguez; Katherine T Cost; Kate M Neufeld; Reva Schachter; Daphne J Korczak Journal: Lupus Date: 2021-06-02 Impact factor: 2.911